Search Results - Esdur, Pinar Coban

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    A novel prognostic biomarker in progression free survival for patients with cervical cancer, glucose to c-reactive protein ratio (GCR)

    A novel prognostic biomarker in progression free survival for patients with cervical cancer, glucose to c-reactive protein ratio (GCR) by Buyukbayram, Mehmet Emin, Hannarici, Zekeriya, Turhan, Aykut, Caglar, Alperen Akansel, Esdur, Pınar Çoban, Bilici, Mehmet, Tekin, Salim Basol, Erdemci, Burak

    Published in BMC cancer
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker

    The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker by Buyukbayram, Mehmet Emin, Hannarici, Zekeriya, Duzkopru, Yakup, Turhan, Aykut, Caglar, Alperen Akansel, Coban Esdur, Pınar, Bilici, Mehmet, Tekin, Salim Basol, Yazılıtaş, Doğan

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    The Effect of C-Reactive Protein/Lymphocyte Ratio

    The Effect of C-Reactive Protein/Lymphocyte Ratio by Caglar, Alperen Akansel, Hannarici, Zekeriya, Yazilitas, Dogan, Turhan, Aykut, Tekin, Salim Basol, Buyukbayram, Mehmet Emin, Bilici, Mehmet, Duzkopru, Yakup, Esdur, Pinar Coban

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Inflammatory parameters in NSCLC with driver mutation

    Inflammatory parameters in NSCLC with driver mutation by Buyukbayram, Mehmet Emin, Hannarici, Zekeriya, Yilmaz, Ali, Turhan, Aykut, Caglar, Alperen Akansel, Esdur, Pınar Coban, Bilici, Mehmet, Tekin, Salim Basol

    Published in Lung cancer management
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  5. 5
    Tumor Lysis Syndrome Due to Pembrolizumab Use in Metastatic Nasopharyngeal Carcinoma

    Tumor Lysis Syndrome Due to Pembrolizumab Use in Metastatic Nasopharyngeal Carcinoma by Aykut Turhan, Zekeriya Hannarici, Mehmet Emin Büyükbayram, Alperen Akansel Çağlar, Pınar Çoban Eşdur, Mehmet Bilici, Salim Başol Tekin

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: